U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06943768) titled 'Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test' on March 20.
Brief Summary: This is a multicenter, cross-sectional study. It is based on fecal methylation site detection, H. pylori susceptibility testing of fecal samples, and a combination of the two, compared with the "gold standard" imaging tests, CT, gastroscopy and/or pathology, for gastric cancer, benign diseases such as gastritis, and health check-ups.
Study Start Date: June 01
Study Type: OBSERVATIONAL
Condition:
Gastric (Stomach) Cancer
Intervention:
DIAGNOSTIC_TEST: fecal methylation site-based testing and fecal Helicobacter py...